Catalyst Wire Dossier Catalyst Wire Dossier

HRS-7535 tablets

HRS-7535 · Shandong Suncadia Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HRS-7535 tablets, covering 2025-11-17 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i. [Phase 2]

See pricing